Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports
Top Cited Papers
- 15 August 2007
- journal article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 62 (4), 345-354
- https://doi.org/10.1016/j.biopsych.2006.09.023
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms?The Lancet Neurology, 2006
- Bupropion for major depressive disorder: Pharmacokinetic and formulation considerationsClinical Therapeutics, 2005
- In Vivo Modulatory Action of Extracellular Glutamate on the Anticonvulsant Effects of Hippocampal Dopamine and SerotoninEpilepsia, 2005
- Major depression is a risk factor for seizures in older adultsAnnals of Neurology, 2000
- Seizures and SchizophreniaSchizophrenia Bulletin, 1997
- Reduction of seizure frequency with clomipramine in patients with complex partial seizuresBrain & Development, 1995
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993
- Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in RatsEpilepsia, 1993
- Relative toxicity of cyclic antidepressantsAnnals of Emergency Medicine, 1986
- The use of imipramine in minor motor seizuresPediatric Neurology, 1986